

	Sharon M. Luboff - Bard Leadership - Directors & Officers | Bard

















































You are now leaving the Bard Website. Any links or references to other Internet sites (hyperlinks) are provided by Bard merely as a convenience to users of this Internet site. Any hyperlink to such other Internet site does not imply any endorsement or recommendation by Bard or its Affiliates. Please see our Terms of Use section for additional information. Before acting on any advice or information related to your healthcare that you find at the following or any other website, contact a Healthcare Professional.

Cancel

Proceed


Proceed










































Skip to main content








Welcome to the C.R. Bardsite for Patients
Please note that this information provided by BARD is not intended to be used in place of a visit, consultation, or advice of a medical professional. Information is as of 06/2017.  Please check references for updated information.

Cancel
Proceed

 













Welcome to the C.R. Bard site for Healthcare Professionals
You are entering a section of this website that is intended for healthcare providers. If you are a healthcare provider, please click 'Proceed' to continue.

Cancel
Proceed

 













Welcome to the C. R. Bardsite for Healthcare Professionals
The webpages you are accessing and their content are intended only for healthcare professionals with knowledge and expertise in the area of healthcare economic analysis and who are seeking information to review products within a value analysis framework. By clicking “Agree” you represent that you are such a healthcare professional.

Disagree
Agree

 













    Sharon Luboff | C. R. Bard , Inc. | ZoomInfo.com


Sharon M Luboff - Florham Park, NJ | Intelius



























Sign In



We found Sharon M Luboff in Florham Park, NJ


Sharon M Luboff

                                                                                       Intelius found that Sharon M Luboff  is  a female between 50 and 60 years old from Florham Park, NJ.  We have connected them to
                17 addresses,
                13 phones,
                and 5 relatives or associates.
         





Also Known As

Sharon M Alterio


Get Report Now

Age

Sharon M Luboff is in her 50s

Sharon Has Lived In

Florham Park, NJ
Covington, GA
Fort Lauderdale, FL

Sharon's Relatives

Frank Alterio
Bianca Alterio
David Moss
Adam Alterio







Sharon M Luboff



Zodiac SignVirgo



GenderFemale



Professional Status
Group Vice President at C. R. Bard , Inc.



Get Report Now










Want to know more about Sharon? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Sharon, or use our people search engine to find others.
Get Background Check on Sharon M Luboff
Get a Criminal Check on Sharon M Luboff
Get a Public Record Report on Sharon M Luboff
Get a People Search Report on Sharon M Luboff


Sharon M Luboff's Contact Information
Known Cities Lived In
Find out where Sharon M Luboff has lived as well as Sharon M Luboff's phone numbers and email addresses.




Sharon M Luboff Has Lived in 5 States
New Jersey Address for Sharon M Luboff


88 M***** D* 

Florham Park, NJ


Has Lived In

Florham Park, NJ
Covington, GA


Get Full Address Report










Phone Numbers Associated with Sharon M Luboff

(908) ***-**** - New Providence, NJ 
(908) ***-**** - New Providence, NJ 
(630) ***-**** - Itasca, IL 


Get Full Phone Report



Email Addresses Associated with Sharon M Luboff

s****n@***.com
s*******1@***.com
a*****o@***.com


Get Email Report




Sharon M Luboff's Professional Information
Information regarding Sharon M Luboff's professional history.  Find out previous places Sharon M Luboff has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Sharon M Luboff Has Worked at 8 Places
Company: C. R. Bard , Inc.
               Title: Group Vice President
Company: C. R. Bard , Inc.
               Title: President, Bard Medical Division
Sharon M Luboff's Experience
Title: Group Vice President
               Company: C. R. Bard , Inc.
Job Details
               Company Size: $1 bil and above - Employee Range: 5,000 to less than 25,000. Nature of business: C. R. Bard, Inc. (NYSE: BCR) is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialty products. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard has been a public company since 1963 and a member of the New York Stock Exchange since 1968.
Title: President, Bard Medical Division
               Company: C. R. Bard , Inc.
Job Details
               Nature of business: C. R. Bard, Inc. (NYSE: BCR) is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialty products. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard has been a public company since 1963 and a member of the New York Stock Exchange since 1968.
Additional Professional Information on Sharon M Luboff

 See Sharon M Luboff's LinkedIn Profile



Sharon M Luboff's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Sharon M Luboff


Sharon M Luboff's known Social Networks And Potential Email Matches

Find all of Sharon M Luboff's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Sharon Luboff
Username Matches

                  SharonLuboff
                  LuboffSharon
                  Sharon.Luboff
                  Luboff.Sharon
                  Sharon_Luboff
                  Luboff_Sharon
                  Sharon-Luboff
                  Luboff-Sharon
                  SLuboff
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
S Luboff







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.






















 



C R Bard Inc (BCR)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















C R Bard Inc (BCR)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareMedical Equipment, Supplies & Distribution












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				BCR on New York Consolidated


				322.01USD
25 Jul 2017





				    Change	(% chg)


		    
						    $-0.10


					            (-0.03%)
					        






Prev Close

$322.11


Open

$322.83




Day's High

$323.27


Day's Low

$321.34




Volume

358,445


Avg. Vol

886,911




52-wk High

$323.27


52-wk Low

$203.63











					Summary





Name
Age
Since
Current Position




							Timothy Ring

59
2003

                                Chairman of the Board, Chief Executive Officer




							John Weiland

61
2016

                                President, Vice Chairman of the Board, Chief Operating Officer




							James Beasley

53
2013

                                Group President




							Timothy Collins

56
2013

                                Group President




							John Groetelaars

50
2015

                                Group President




							Christopher Holland

50
2012

                                Chief Financial Officer, Senior Vice President




							Samrat Khichi

49
2014

                                Senior Vice President, General Counsel, Secretary




							John DeFord

55
2007

                                Senior Vice President - Science, Technology and Clinical Affairs




							Frank Lupisella

56
2006

                                Vice President, Controller




							Betty Larson

41
2014

                                Vice President - Human Resources




							Sharon Luboff

54
2009

                                Group Vice President




							Gerard Porreca

53
2016

                                Vice President - Quality, Regulatory and Medical Affairs




							David Barrett

74
2009

                                Independent Director




							Robert Davis

50
2016

                                Independent Director




							Herbert Henkel

68
2014

                                Independent Director




							John Kelly

74
2009

                                Independent Director




							David Melcher

62
2016

                                Independent Director




							Gail Naughton

61
2004

                                Independent Director




							Tommy Thompson

75
2005

                                Independent Director




							Anthony Welters

62
1999

                                Independent Director




							Tony White

70
1996

                                Independent Director




							Todd Garner




                                Vice President - Investor Relations



» Insider Trading





					Biographies





Name
Description




							Timothy Ring


					
							Mr. Timothy M. Ring is Chairman of the Board, Chief Executive Officer of the Company. Mr. Ring has served as Chairman and Chief Executive Officer of the Company since August 2003, having been Group President from April 1997 to August 2003, Group Vice President from December 1993 to April 1997 and Vice President-Human Resources from June 1992 to December 1993. He is also a director of Quest Diagnostics Incorporated. Mr. Ring has been nominated to serve an additional term as a director due to his prior service on C. R. Bard’s Board and more than 20 years of experience in various leadership capacities at C. R. Bard, including as the Company’s Chairman and Chief Executive Officer. He was previously responsible for the Company’s global Vascular and Specialty Access businesses. Mr. Ring has been instrumental in developing and implementing C. R. Bard’s current strategic direction. Prior to joining the Company, he gained valuable experience in leadership roles at Abbott Laboratories in both human resources and general management. Mr. Ring is a Trustee of the Foundation of The University of Medicine & Dentistry of New Jersey. He holds a B.S. in Industrial and Labor Relations from Cornell University.




							John Weiland


					
							Mr. John H. Weiland is President, Vice Chairman of the Board, Chief Operating Officer of the Company. Mr. Weiland was elected as Vice Chairman in August 2016 and has served as President and Chief Operating Officer of the Company since August 2003, having been Group President from April 1997 to August 2003 and Group Vice President from March 1996 to April 1997. Mr. Weiland joined C. R. Bard from Dentsply International, where he was a Senior Vice President, until March 1996. He is also a director of West Pharmaceutical Services, Inc. Mr. Weiland has been nominated to serve an additional term as a director as a result of his extensive knowledge and experience in the medical device industry, his prior service on C. R. Bard’s Board, and more than 20 years of experience in various leadership capacities at the Company. Mr. Weiland joined C. R. Bard in 1996 as Group Vice President and was promoted to Group President in 1997, with responsibility for C. R. Bard’s Surgical, Urological and Endoscopic Technology businesses, and its worldwide manufacturing operations. He was promoted to President and Chief Operating Officer in August 2003. Mr. Weiland also held senior management positions at Dentsply International, American Hospital Supply and Baxter Healthcare. In 1987, he was named a White House Fellow and served as a Special Assistant to two members of President Reagan’s cabinet. Mr. Weiland is a 2012 recipient of the prestigious Horatio Alger Award and serves as a director of the Horatio Alger Association. Mr. Weiland received a B.S. in Biology from DeSales University and an M.B.A. from New York University.




							James Beasley


					
							Mr. James C. Beasley is Group President of the Company. He joined Bard in 1989 as a territory sales manager for Bard Interventional Products. He has held a succession of management positions including President of Bard Access Systems division from 2003 to 2007 and President of Bard Peripheral Vascular division from 2007 to 2012. In 2009, Mr. Beasley was promoted to Group Vice President and assumed responsibility for both divisions. From January 2012 to July 2013, Mr. Beasley also had responsibilities for Bard’s businesses in Japan, Asia (excluding China) and Australia. In July 2013, Mr. Beasley was promoted to Group President and assumed responsibilities for Bard’s businesses in Latin America while continuing to be responsible for the Bard Access Systems (through June 2015) and Bard Peripheral Vascular divisions, and Bard’s business in Japan. In July 2015, He assumed additional responsibilities for driving a new market development process across Bard to enable and accelerate the company’s growth in new and developing markets.




							Timothy Collins


					
							Mr. Timothy P. Collins is Group President of the Company. He joined Bard in 1986 as a facilities planner with the USCI division. Over the next 12 years, Mr. Collins held positions of increasing responsibility including Director of Operations for Diagnostic Cardiology. Concurrent with the sale of Bard’s cardiology business, Mr. Collins joined Medtronic Vascular in 1998 as Vice President/Business Unit Manager in Medtronic/AVE and was later appointed Vice President, Global Operations, Vascular. Mr. Collins returned to Bard and was President of the Bard Electrophysiology division from 2003 to 2008. In 2008, Mr. Collins was promoted to Group Vice President responsible for worldwide manufacturing operations and also assumed responsibility for the Electrophysiology division, until its sale in November 2013. In January 2012, Mr. Collins assumed additional responsibility for Bard’s businesses in Canada. In July 2013, Mr. Collins was promoted to Group President and assumed additional responsibility for Bard’s businesses in Europe. In July 2015, Mr. Collins assumed additional responsibilities for Bard Medical division.




							John Groetelaars


					
							Mr. John P. Groetelaars is Group President of the Company. Mr. Groetelaars joined Bard in 2008 as Vice President and General Manager of the Davol division. Mr. Groetelaars was President of the Davol division from 2009 to 2013. In July 2013, Mr. Groetelaars was promoted to Group Vice President and assumed additional responsibilities for Bard’s businesses in China, Asia and Australia while continuing to be responsible for Bard’s Davol division. In July 2015, Mr. Groetelaars was promoted to Group President and added Bard Access Systems to his current responsibilities. Prior to joining Bard, Mr. Groetelaars held positions of increasing responsibility with Boston Scientific Corporation from 2001 until joining Bard and having most recently served as General Manager and Vice President for UK, Ireland and Nordic Regions.




							Christopher Holland


					
							Mr. Christopher S. Holland is Chief Financial Officer, Senior Vice President of the Company. He joined Bard in 2012 as Senior Vice President and Chief Financial Officer. From July 2013 through June 2015, Mr. Holland had responsibility for Bard Medical division. In July 2015, Mr. Holland assumed responsibilities for Business Development, Corporate Marketing, Reimbursement, Healthcare Economics and Strategy. Prior to joining Bard, he held executive positions at ARAMARK Corporation since 2003 and was most recently Senior Vice President, Finance and Treasurer. Previously, Mr. Holland held various positions at J.P. Morgan and Company, Inc., including Vice President, with responsibility for the medical device sector.




							Samrat Khichi


					
							Mr. Samrat S. Khichi is Senior Vice President, General Counsel, Secretary of the Company. Mr. Khichi joined Bard in July 2014 as Senior Vice President, General Counsel and Secretary. Prior to joining Bard, Mr. Khichi was Chief Administrative Officer, Senior Vice President, General Counsel and Secretary at Catalent Pharma Solutions, Inc, a portfolio company of The Blackstone Group, since 2007. Previously, Mr. Khichi served as Counsel, Mergers and Acquisition and Private Equity for O’Melveny & Myers LLP.




							John DeFord


					
							Dr. John A. DeFord, Ph.D., is Senior Vice President-Science, Technology and Clinical Affairs of Company. Dr. DeFord joined Bard in 2004 as Vice President, Science & Technology after serving as Managing Director with Early Stage Partners, LLP (ESP), a venture capital fund, from 2002 until 2004. Before joining ESP he was President and CEO of Cook Incorporated, a privately-held medical device Company. He was promoted to Senior Vice President-Science, Technology & Clinical Affairs in 2007.




							Frank Lupisella


					
							Mr. Frank Lupisella Jr., is Vice President, Controller of the Company. Mr. Lupisella joined Bard in 1987 and has served in various capacities in the finance organization of the company. Mr. Lupisella served as Vice President and Controller of the Davol division from 1999 until 2005 when he was promoted to Assistant Corporate Controller, Manufacturing Operations. In 2006, he was promoted to his present position of Vice President and Controller of the company.




							Betty Larson


					
							Ms. Betty D. Larson is Vice President - Human Resources of the Company. Ms. Larson joined Bard in September 2014 as Vice President, Human Resources. Prior to joining Bard, She held positions of increasing responsibility with Baxter Healthcare Corporation from 1999 until joining Bard and having most recently served as Vice President, Human Resources – Global Medical Products Business.




							Sharon Luboff


					
							Ms. Sharon M. Luboff is Group Vice President of the Company. She joined Bard in 2004 as President of Bard Medical division. Ms. Luboff was promoted to Group Vice President and was responsible for Bard’s international businesses from 2009 to 2013 and for Bard Medical division from 2012 to 2013. In July 2013, Ms. Luboff assumed responsibility for Corporate Marketing, Reimbursement, Healthcare Economics and Business Development and Strategy. Prior to joining Bard, she held positions at Baxter Healthcare including Vice President, Global Therapeutic Marketing for its Renal Division.




							Gerard Porreca


					
							Mr. Gerard D. Porreca III is Vice President - Quality, Regulatory and Medical Affairs of the Company. Prior to joining Bard, Mr. Porreca was Senior Vice President, Global Regulatory Affairs and Quality Assurance and Chief RA/QA Officer at Smith and Nephew PLC since 2011.




							David Barrett


					
							Dr. David M. Barrett, M.D. is Independent Director of the Company. He is Emeritus President and Chief Executive Officer of Lahey Clinic (a nonprofit, multispecialty healthcare organization). Dr. Barrett retired from his position as President and CEO of Lahey Clinic having served in this role from September 1999 to November 2010 and as a member of its Board of Trustees and Chair of the Board of Governors from September 1999 to November 2010, having been Chair of the Department of Urology of the Mayo Clinic, Vice Chair of the Board of Governors, Trustee of the Mayo Foundation and a member of its Executive Committee since 1975. He is Emeritus Anson L. Clark Professor of Urology at the Mayo Clinic Medical School and currently Clinical Professor of Surgery at Dartmouth Medical School. Dr. Barrett is an Emeritus Trustee of the Lahey Clinic and the Mayo Clinic. Dr. Barrett served as a flight surgeon in the U.S. Air Force. Dr. Barrett was formerly a director of ProUroCare Medical, Inc. Dr. Barrett has been nominated to serve an additional term as a director as a result of, among other things, the breadth of healthcare experience that he brings to C. R. Bard. As President and Chief Executive Officer of Lahey Clinic, Dr. Barrett oversaw one of the largest healthcare systems in New England. He also currently serves on the executive and compensation committees and as chair of the governance committee of the CommonFund, an institutional investment firm that works with the nonprofit and pension investment communities. Dr. Barrett also serves as a director of AdvantEdge Health Solutions, a privately-held medical billing company. In addition, before joining Lahey Clinic in September 1999, he had a distinguished career as a physician, teacher and administrator at the Mayo Clinic. Dr. Barrett is an authority on urologic oncology, urinary incontinence, bladder reconstruction and genitourinary prostheses. He is the former president of the Urodynamic Society, the American Board of Urology and the American Association of Genitourin




							Robert Davis


					
							Mr. Robert M. Davis is an Independent Director of the Company. He is Executive Vice President and Chief Financial Officer of Merck & Co., Inc. (“Merck”) (global health care company) since April 2014. Prior to that, Mr. Davis served as Corporate Vice President and President of Baxter Renal Division from June 2010 to October 2010 and Corporate Vice President and President of Baxter Medical Products from October 2010 to April 2014, having been Corporate Vice President and Chief Financial Officer of Baxter Healthcare from May 2006 to June 2010, and Treasurer of Baxter Healthcare from November 2004 to May 2006. He also served as Director of Corporate Financial Planning of Eli Lilly and Company from 2002 to 2004, and as Assistant Treasurer and various financial positions at Eli Lilly and Company from 1990 to 2002. Mr. Davis has been nominated to serve as a director as a result of, among other things, his significant experience in management, strategy, business development, finance, accounting for public companies and technical operations for global companies. This experience includes his service as the Chief Financial Officer of Merck, as well as his prior experience gained in a variety of management and finance roles at Baxter International. He holds both a B.S. in business from Miami University in Ohio, as well as an M.B.A. and a J.D. from Northwestern University in Chicago.




							Herbert Henkel


					
							Mr. Herbert L. Henkel is an Independent Director of the Company. He is Retired Chairman and Chief Executive Officer of Ingersoll-Rand Company (a global diversified industrial company). Mr. Henkel served as Chairman from February 2010 to June 2010, having been Chairman and Chief Executive Officer from May 2000 to February 2010, President and Chief Executive Officer from October 1999 to May 2000 and President and Chief Operating Officer from April to October 1999. Prior to that, Mr. Henkel served as President and Chief Operating Officer of Textron, Inc. from 1998 to 1999, having been President of Textron Industrial Products from 1995 to 1998. He is also a director of 3M Company, Allstate Corporation and Herc Holdings Inc. Mr. Henkel was formerly a director of Visteon Corporation. Mr. Henkel served as lead director from January 1, 2011 until June 30, 2014. Mr. Henkel has been nominated to serve an additional term as a director as a result of the breadth and significance of his experience in management, sales and marketing, as well as research and technical operations for global companies in a variety of industries. This experience includes his service as the Chairman and Chief Executive Officer of Ingersoll-Rand Company, a global diversified industrial company, as well as his prior service on C. R. Bard’s Board and experience on the audit, governance and nominating committees of other large public companies. He holds both a B.S. and an M.S. in engineering from Polytechnic University of New York, as well as an M.B.A. from Pace University, New York.




							John Kelly


					
							Mr. John C. Kelly is Independent Director of the Company. He is Former Senior Vice President, Finance of Pfizer Inc. (pharmaceutical products). Mr. Kelly served as Senior Vice President, Finance of Pfizer Inc. from October 2009 to February 2010, having been Vice President and Controller of Wyeth (pharmaceutical and healthcare products) since March 2008. Mr. Kelly held various other positions, including Vice President, Finance Operations, since joining Wyeth in 2002. He is also a director of The Medicines Company. Mr. Kelly has been nominated to serve an additional term as a director as a result of over 45 years of experience in accounting and finance, as well as his background in healthcare. Prior to joining Wyeth (and then Pfizer), where he handled a wide range of assignments in finance, he spent more than 35 years in public accounting at Arthur Andersen in various leadership capacities, including as the partner in charge of audit and business consulting practices in the New York metropolitan area. He is a certified public accountant and was an elected member of the Council of the American Institute of Certified Public Accountants. He earned both his B.S. in business administration and M.B.A. in international finance from Seton Hall University.




							David Melcher


					
							Lt. Gen. David F. Melcher is an Independent Director of the Company. He is President and Chief Executive Officer of Aerospace Industries Association (a trade association representing major aerospace and defense manufacturers and suppliers) since June 2015. Prior to that, Lieutenant General (Ret.) Melcher served as Chief Executive Officer, President and member of the Board of Directors of Exelis Inc. (a diversified, global aerospace defense, information and technology services company) from November 2011 to May 2015, having been President of ITT Defense & Information Solutions from December 2008 until the spin-off of Exelis Inc. from ITT in October 2011. Mr. Melcher also served as Vice President of Strategy and Business Development for ITT Defense & Information Solutions from August 2008 to December 2008, following 32 years of distinguished service in the U.S. Army. He currently serves on the Executive Committee and Board of Governors of the Aerospace Industries Association. Mr. Melcher has been nominated to serve an additional term as a director as a result of his significant leadership in program management, strategy development and finance, as well as extensive international strategic business, budget and policymaking experience gained during more than 25 years of leadership positions in the defense community, including his role as Chief Executive Officer and President of Exelis Inc. He has also demonstrated leadership and management experience with the U.S. Army, having served as the Army’s Military Deputy for Budget and Deputy Chief of Staff for Programs in the Pentagon, and as Commander of the Corps of Engineers, Southwestern Division in Dallas, Texas. He is a 2014 recipient of the Association of the United States Army John W. Dixon award for contributions to the Defense Industry.




							Gail Naughton


					
							Dr. Gail K. Naughton, Ph.D. is Independent Director of the Company. She is Chairman and Chief Executive Officer of Histogen, Inc. (regenerative medicine). Dr. Naughton has served as the Chairman and Chief Executive Officer of Histogen, Inc. since June 2007, having been Vice Chairman of Advanced Tissue Sciences, Inc. (ATS) (human-based tissue engineering) from March 2002 to October 2002, President from August 2000 to March 2002, President and Chief Operating Officer from 1995 to 2000 and Co-Founder and Director since inception in 1991. Dr. Naughton also served as Dean of the College of Business Administration at San Diego State University from August 2002 to June 2011. She is also a director of Cytori Therapeutics, Inc. Dr. Naughton has been nominated to serve an additional term as a director because of the breadth of her life sciences industry knowledge and experience, including her experience as Chairman and Chief Executive Officer of Histogen, Inc. Dr. Naughton was the first woman to be awarded the National Inventor of the Year award by The Intellectual Property Owners Association. She has conducted extensive research, authored numerous scientific publications and holds more than 95 U.S. and foreign patents. Dr. Naughton has also built a distinguished academic career, including serving as the Dean of the College of Business Administration, San Diego State University and on the boards of several academic institutions, non-profit organizations and foundations. Dr. Naughton earned a B.S. from St. Francis College, Brooklyn, New York, and both an M.S. in Histology and a Ph.D. in Hematology from New York University Medical Center. She also holds an M.B.A. in Executive Management from the Anderson School at the University of California, Los Angeles.




							Tommy Thompson


					
							Gov. Hon. Tommy G. Thompson, J.D., is Independent Director of the Company. He is Former Secretary of the U.S. Department of Health and Human Services. Mr. Thompson served as Secretary of the U.S. Department of Health and Human Services from January 2001 to January 2005, having been Governor of Wisconsin from November 1986 to January 2001. He is also Chairman and Chief Executive Officer of Thompson Holdings (a consulting firm) since 2012. Mr. Thompson also serves as an adjunct senior advisor at the Akin Gump Strauss Hauer & Feld LLP law firm since January 2017, having been a partner of the law firm from March 2005 to January 2012. He served as Independent Chairman of the Deloitte Center for Health Solutions from March 2005 to May 2009. Mr. Thompson was Chairman of the Board of Logistics Health, Inc. from January 2011 to June 2011, having been President of Logistics Health, Inc. from February 2005 to January 2011. He is also a director of Centene Corporation, Physicians Realty Trust, United Therapeutics Corporation and Therapeutics MD, Inc. Mr. Thompson was formerly a director of Cancer Genetics, Inc., CareView Communications, Inc., Cytori Therapeutics, Inc., PURE Bioscience, SpectraScience, Inc. and Tyme Technologies, Inc. Mr. Thompson has been nominated to serve an additional term as a director as a result of his significant experience in the healthcare industry, both as a public official and in the private sector. As Secretary of the U.S. Department of Health and Human Services, he oversaw the principal public agency for protecting the health of Americans and providing essential human services through its eleven divisions, including the U.S. Food and Drug Administration, the Office of Inspector General, the Center for Medicare and Medicaid Services, and the Centers for Disease Control and Prevention.




							Anthony Welters


					
							Mr. Anthony Welters is Independent Director of the Company. He is Executive Chairman of BlackIvy Group, LLC (a private investment company focused on investments in Sub-Saharan Africa) since January 2013. Mr. Welters served as Senior Advisor to the Chief Executive Officer of UnitedHealth Group, Inc. (a diversified health and well-being company) from January 2013 to January 2016, having served as Executive Vice President of UnitedHealth Group, Inc. from November 2006 to January 2013 and as a Member of the Office of the Chief Executive Officer from January 2011 to January 2013. He also served as President of the Public and Senior Markets Group from September 2007 to December 2010. Mr. Welters has also served as President and Chief Executive Officer of AmeriChoice Corporation, a UnitedHealth Group Company, and Chairman and Chief Executive Officer of AmeriChoice Corporation and its predecessor companies from 1989 until its acquisition by UnitedHealth Group. He is also a director of Loews Corporation and The Carlyle Group. Mr. Welters has been nominated to serve an additional term as a director as a result of over 25 years of experience in the healthcare industry and his prior service on C. R. Bard’s Board. This experience includes his service as Executive Vice President of UnitedHealth Group, which designs products, provides services and applies technologies designed to improve access to health and well-being services. He is a recipient of the prestigious Horatio Alger Award and serves as a director of the Horatio Alger Association. He is also Emeritus Chairman of the Board of Trustees for the Morehouse School of Medicine in Atlanta. Mr. Welters holds a B.A. from Manhattanville College and a J.D. from New York University School of Law.




							Tony White


					
							Mr. Tony Lee White is Independent Director of the Company. He is Retired Chairman, President and Chief Executive Officer of Applied Biosystems, Inc. (formerly Applera Corporation). Mr. White served as Chairman, President and Chief Executive Officer of Applied Biosystems, Inc. from September 1995 through November 2008. He is also a director of CVS Health Corp. and Ingersoll-Rand Company. Mr. White was appointed as lead director effective July 2014. Mr. White has been nominated to serve an additional term as a director as a result of his significant experience in the life sciences industry. His experience includes his service as Chairman, President and Chief Executive Officer of Applied Biosystems, Inc., a life sciences and products company, as well as his prior service on C. R. Bard’s Board and experience on both the executive and compensation committees of other large public companies. He also held a number of management positions both in the United States and internationally during a 26-year career at Baxter International, Inc. Mr. White received his B.A. from Western Carolina University.




							Todd Garner














					Basic Compensation





Name
Fiscal Year Total




							Timothy Ring

12,626,500




							John Weiland

7,121,000




							James Beasley

4,290,960




							Timothy Collins

4,309,940




							John Groetelaars

--




							Christopher Holland

3,949,350




							Samrat Khichi

--




							John DeFord

--




							Frank Lupisella

--




							Betty Larson

--




							Sharon Luboff

3,251,450




							Gerard Porreca

--




							David Barrett

288,802




							Robert Davis

288,802




							Herbert Henkel

301,902




							John Kelly

332,152




							David Melcher

303,802




							Gail Naughton

293,552




							Tommy Thompson

283,902




							Anthony Welters

286,902




							Tony White

317,302




							Todd Garner

--



As Of 
30 Dec 2016





					Options Compensation





Name
Options
Value




							Timothy Ring

1,503,891
67,085,030




							John Weiland

818,685
29,430,160




							James Beasley

21,340
1,705,610




							Timothy Collins

25,967
2,991,000




							John Groetelaars

0
0




							Christopher Holland

7,941
949,034




							Samrat Khichi

0
0




							John DeFord

0
0




							Frank Lupisella

0
0




							Betty Larson

0
0




							Sharon Luboff

10,585
363,328




							Gerard Porreca

0
0




							David Barrett

0
0




							Robert Davis

0
0




							Herbert Henkel

0
0




							John Kelly

0
0




							David Melcher

0
0




							Gail Naughton

0
0




							Tommy Thompson

0
0




							Anthony Welters

0
0




							Tony White

0
0




							Todd Garner

0
0









					Insider Trading












Name
Shares Traded
Price


Welters (Anthony)
662
$309.25


Welters (Anthony)
1,200
$81.70


Welters (Anthony)
1,200
$88.76


Welters (Anthony)
325
$308.35


Welters (Anthony)
1,200
$83.47


Thompson (Tommy G)
700
$83.47


Thompson (Tommy G)
190
$308.00


White (Tony Lee)
1,200
$83.47


Lupisella Frank  Jr
3,622
$304.00


Beasley (James C.)
4,390
$245.00


Beasley (James C.)
4,390
$186.43


Holland (Christopher S)
618
$240.53


Deford John A
2,788
$240.51


Groetelaars John P
732
$240.49


Luboff (Sharon M.)
3,659
$240.53


Beasley (James C.)
3,213
$240.52


Ring (Timothy M)
14,425
$240.50


Weiland (John H)
14,091
$240.49


Collins (Timothy P)
3,768
$240.50


Weiland (John H)
1,274
$240.00


Collins (Timothy P)
600
$240.47


Weiland (John H)
1,055
$240.47


Deford John A
469
$240.07


Luboff (Sharon M.)
1,000
$86.15


Ring (Timothy M)
1,856
$240.47




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareMedical Equipment, Supplies & Distribution
























Sharon M. Luboff of C.R. Bard Inc Executive Profile

















 





 



C.R. Bard Inc
 BCR


OverviewExecutive CompensationInsider ActivityKey ExecutivesBoard of DirectorsCommittees
 


Key Executives
                > Sharon M. Luboff
            
Sharon M. Luboff, Group Vice President



Profile
Connections






Biography



    Sharon M. Luboff joined Bard in 2004 as President of Bard Medical division. Ms. Luboff was promoted to Group Vice President and was responsible for Bard's international businesses from 2009 to 2013 and for Bard Medical division from 2012 to 2013. In July 2013, Ms. Luboff assumed responsibility for Corporate Marketing, Reimbursement, Healthcare Economics and Business Development and Strategy. Prior to joining Bard, Ms. Luboff held positions at Baxter Healthcare including Vice President, Global Therapeutic Marketing for its Renal Division.
    





Board Membership




Sharon M. Luboff is not a member of any boards




 


  













Sharon M. Luboff , C. R. Bard, Inc. [BARD] - Leadership® Profile

































Products


Resources


About 


Client Support


Order








Leadership® ProfileLast changed: 7/24/2017  
Sharon M. Luboff  
Group Vice PresidentC. R. Bard, Inc. [BARD]
Telephone, Fax, and Education History available

Total Positions available: 1

Career History includes:
President,  C.R. Bard, Inc., Bard Medical Division , (2004-2008) 
(2 additional careers available)


 Purchase This Profile
Request Free Trial


Subscribe to one of these Leadership® Online products for unlimited access:
Leadership® Companies Premium Leadership Networks® Leadership® Health Focus The Leadership Library®


About Leadership Directories, Inc. [LDI]

	Leadership Directories, Inc. [LDI] is a B2B information services company which provides premium content and contact solutions. LDI researches and publishes verified profiles of influential people and organizations from the federal government, state and local governments, public and private companies, law firms and courts, media outlets, healthcare organizations, nonprofits and associations, and the U.S. Congress.LDI's unique database of 900,000 contacts and 165,000 organizations is available online, in print, and as custom data services. Our high-quality data is updated daily with 4,000+ changes verified by NYC- and DC-based staff.


 




                Toll free: 1-800-627-0311

                1407 Broadway, Suite 318, New York, NY 10018
Tel: (212) 627-4140     Fax: (212) 645-0931
            

                1667 K Street, NW, Suite 801, Washington, DC 20006
Tel: (202) 347-7757       Fax:
                (202) 628-3430
            




Terms of use

|

Privacy Policy

|

FAQ

|

Contact us


 ©  Leadership Directories, Inc.
            












C.R. Bard Inc (BCR) Group Vice President Luboff Sharon M's Insider Stock Buys and Sells 



























Home




 Homepage


 Membership Levels


 Membership Data Coverage


 Complete Stock List


 Founder's Message


 The Book


 FREE Trial






Screeners


Value Screens 


 All-In-One Screener


 Industry Overview


 Ben Graham Net-Net


 Undervalued Predictable


 Buffett-Munger Screener


 Magic Formula (Greenblatt)


 Historical Low P/S List


 Historical Low P/B List


 Peter Lynch Screen


 High Short Interest


 52-Week/3Y/5Y Lows


 52-Week/3Y/5Y Highs


 Predictable Companies


 S&P 500 Grid


 Dividend Stocks


 Spin Off List




Downloads | Tools


  Excel Add-In GURUF


 Manual of Stocks™


 Download Financial Data


 Download Guru Portfolios


 Download Stock PDFs


 Download Insider Data


  API


 Mobile App




Strategies


 Performances


 Buffett-Munger


 Undervalued Predictable


 Low P/S


 Low P/B


 Broadest Owned


 Most Weighted






Gurus




 Latest Guru Picks


 Real Time Picks


 List of Gurus (Personalize)


 Gurus Portfolios


 Scoreboard


 Top 10 Holdings View


 Sector Picks


 International Picks


 Aggregated Portfolio


 Consensus Picks


 Guru Bargains


 Hot Picks


 Industry Trends


 Geographic Trend


 ETFs


 Options


 European Shorting






Insiders




 All Insiders


 CEO Buys/Sales


 CFO Buys/Sales


 Insider Cluster


 Guru+Insider Double Buys


 Triple Buys/Sales


 Insider Trends


 Canadian Insider


 Dutch Insider






Market


Market Valuation


 Economic Data


 Industry Overview


 Market-Cap/GDP Valuation


 Global Market Valuation


 Shiller P/E


 Shiller P/E By Sectors


 Buffett Assets Allocation




By Country


 USA


 Australia


 Canada


 China


 Germany


 India


 Japan


 UK


 More...






Articles


Articles


 Editor's Picks


 GuruFocus Research


 Value Ideas


 Interviews with Gurus


 Top Ranked


 Value Idea Contest


 Videos


 Following Authors




Submit Articles


 Writers Wanted


 Value Contest Winners


 Submit Articles Online


 My Articles






Conference




 Value Conference


 Speakers


 Location/Venue


 Register


 After Conference Gathering (Free Drinks)






Tutorials




 Tutorials & Webinars


 FAQ


 Contact Us






Log In




 Free Sign-up


 Log In


 7-Day Free Trial 






Subscribe




 Free Trial ($399/Year)


 Refer a Friend & Earn $50














Search
Compare

Search ▾










Get 7-Day Free Trial



My Portfolios▾

Portfolios Overview
Create New Portfolio
Portfolio Contest


My Gurus▾

Quick Browse
Personalize

My Gurus

Premium Gurus 
Premium Plus Investors 





















SummaryCanadian Dutch CEO Buys CFO Buys Insider Cluster Buys Double Buys Triple Buys Data Export Trend  




Saved!




USA

Canada

UK/Ireland

Europe

Asia

Oceania

Latin America

Africa



Currently Selected:



Show All Countries ▾





Purchase to select this region

Purchase $399
USA

OTCPK
NAS
NYSE
ARCA
OTCBB
AMEX
BATS




Purchase to select this region

Purchase $289
Canada

TSXV
TSX
XCNQ




Purchase to select this region

Purchase $269
UK/Ireland

UK




Purchase to select this region

Purchase $399
Europe

Germany
France
Poland
Russia
Sweden
Turkey
Bosnia and Herzegovina
Italy
Luxembourg
Switzerland


Belgium
Greece
Norway
Spain
Denmark
Bulgaria
Netherlands
Romania
Finland
Serbia
Austria
Croatia
Portugal
Slovakia
Cyprus
Macedonia
Slovenia
Ukraine
Hungary
Lithuania
Latvia
Malta
Iceland
Estonia
Czech Republic

All Countries ▾



Purchase to select this region

Purchase $399
Asia

India
Japan
Korea
Thailand
Hongkong
China
Taiwan
Malaysia
Singapore
Israel


Indonesia
Pakistan
Vietnam
Philippines
Sri Lanka
Kuwait
Nepal
Saudi
Jordan
Oman
Iran
Iraq
United Arab Emirates
Kazakhstan
Bahrain

All Countries ▾



Purchase to select this region

Purchase $269
Oceania

Australia
New zealand




Purchase to select this region

Purchase $299
Latin America

Brazil
Mexico
Argentina
Chile
Peru
Columbia
Jamaica
Venezuela
Ecuador




Purchase to select this region

Purchase $249
Africa

South Africa
Egypt
Nigeria
Mauritius
Morocco
Zimbabwe
Kenya
Tunisia
Ghana
Côte d'Ivoire




 Set As Default







Insider Trades


Try Insider Screener



C.R. Bard Inc (BCR) Group Vice President Luboff Sharon M's Insider Stock Buys and SellsTo find out why GuruFocus thinks data on insider trades is interesting, read

Can Aggregated Insider Trading Activities Predict the Market?
Stocks That Both Gurus and Insiders Are Buying
Can Aggregated Insider Trading Activities Predict the Market of Different Sectors?




Filter by:



  Default





Search Insider Trade:




Go




Select to drill down:


All Market CapMicro Cap Small Cap Mid Cap Large Cap Mega Cap S&P 500 Companies All SectorsBasic Materials Consumer Cyclical Financial Services Real Estate Consumer Defensive Healthcare Utilities Communication Services Energy Industrials Technology   Display Those with At Least
100 500 1,000 2,000 5,000 10,000 20,000 50,000 100,000  Shares Display Stocks That are within Please Select 1% 
2% 
3% 
4% 
5% 
8% 
10% 
 of Please Select 52-Week Low3-Year Low5-Year LowReal time insider type:BuySellInsider Sentiment Chart 


 Recent Filings Activity
 

Total Records: 845488   Page:1  2   3   4   5   6   7   8   9   10   LAST (28183) 30 per page ▾ 10 20 2530 50 100



Symbol
Company
Insider
Position
Date
Buy/Sell
Shares
Trade Price ($)
Cost ($1000)
Price ChangeSince Trade (%)
Yield (%)
P/E
Market Cap ($M)
Details

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2017-02-14Sell3,659$240.53880.133.88
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2017-02-13Sell1,478$240.24355.0734.04
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2017-02-09Sell5,801$239.591389.8634.4
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2016-12-12Sell6,000$219131447.04
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2016-04-27Sell10,000$210210053.34
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2016-02-22Sell13,321$1902530.9969.48
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2015-08-18Sell2,374$199.76474.2361.2
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2015-08-17Sell2,030$20040661.01
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2015-08-03Sell5,000$195.99979.9564.3
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2015-07-24Sell2,891$184531.9475.01
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2015-02-19Sell1,117$174.42194.8384.62
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2015-02-17Sell8,772$174.571531.3384.46
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2015-02-03Sell396$170.2167.489.18
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2014-12-17Sell3,564$168.36600.0491.26
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2014-10-27Sell10,000$158.81588102.78
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2014-07-29Sell5,115$151.37774.26112.73
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2014-02-27Sell9,914$144.861436.14122.29
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2014-02-14Sell5,840$139811.76131.66
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2014-02-11Sell1,400$135189138.53
0.3240.9923366.720 Link

BCRC.R. Bard IncLuboff Sharon MGroup Vice Pres...2014-01-13Sell2,500$135337.5138.53
0.3240.9923366.720 Link
Total Records: 845488   Page:1  2   3   4   5   6   7   8   9   10   LAST (28183) 30 per page ▾ 10 20 2530 50 100Add this list into my watchlist/portfolio:

1. Add or remove tickers (Comma separated, up to 500 symbols)
BCR





2. Select destination portfolioYou need to log in to proceed
3. Click the button to finish
 


Related News and Stories: B: comment on B 01-29-2017B: comment on B 12-11-2016B: Note of B 09-09-2016B: BCM Resources Corporation Provides Update on Thompson Knolls Option Agreement 06-14-2016B: BCM Resources Corporation Issues Shares for Debt 05-26-2016B: BCM Resources Corporation: Grant of Incentive Stock Options 05-16-2016B: BCM Resources Corporation Arranges Shares for Debt 04-24-2016B: BCM Resources Corporation Announces Results of Annual and Special Meeting 03-30-2016B: BCM Resources Corporation Appoints New Director and Grants Incentive Stock Options 03-02-2016B: comment on B 03-01-2016B: BCM Resources Corporation: Inland Explorations Successfully Completes Geophysical Surveys at Thompson Knolls 12-17-2015B: BCM Resources Corporation Appoints New Director and V.P. of Exploration 10-30-2015B: BCM Resources Corporation Finalizes Thompson Knolls Agreement & Announces Non-Brokered Private Placement 09-02-2015B: BCM Resources Corporation: Clarification of News Release Announcing Finalization of Thompson Knolls Agreement & Non-Brokered Private Placement 09-02-2015B: BCM Resources Corporation to Option Cu-Au Property in Utah 07-27-2015 Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company. 


 



Select portfolio(s):








                        Create a new portfolio



Why you are interested?



            Your selection and notes will be stored in your portfolio.
        


Login to add portfolio















Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
                    | Earn affiliate commissions by embedding GuruFocus Charts

                                                GuruFocus Affiliate Program: Earn up to $400 per referral.  ( Learn More) 













Home  About   Jobs    Advertise    Site Map    Term of Use    Privacy Policy     RSS    Mobile App     Email Alerts    Referral Program    Affiliate Program    FAQ    Contact Us
                               

                © 2004-2017                GuruFocus.com, LLC. All Rights Reserved.
            


                    Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.



                    Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.


















GF Chat {{numOfNotice}}




























×
Manage BookMarks





Close








FEEDBACK

















Luboff Sharon M Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Luboff Sharon M
                    

•   MURRAY HILL, NJ
                      
How do I update this listing?




                                             Luboff Sharon M is based out of Murray Hill.    WhaleWisdom has at least 15 insider transactions (Form 3,4,5) in our database for Luboff Sharon M. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Luboff Sharon M, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




luboff sharon m


C. R. BARD, INC.

MURRAY HILL
NJ
                                                        
                                                    07974


                                                      Business Phone:
                                                      9082778000
SEC SIC CODE:3841-SURGICAL & MEDICAL INSTRUMENTS & APPARATUS







Recent SEC Filings




4 filed on 02/15/2017
4 filed on 02/14/2017
4 filed on 02/10/2017
4 filed on 12/16/2016
4 filed on 12/14/2016
4 filed on 04/29/2016
4 filed on 02/24/2016
4 filed on 02/18/2016
4 filed on 02/16/2016
4 filed on 02/12/2016
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free




















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft













Robot Check













Enter the characters you see below
Sorry, we just need to make sure you're not a robot. For best results, please make sure your browser is accepting cookies.










Type the characters you see in this image:








Try different image











Continue shopping











Conditions of Use




Privacy Policy


          © 1996-2014, Amazon.com, Inc. or its affiliates
          











Robot Check













Enter the characters you see below
Sorry, we just need to make sure you're not a robot. For best results, please make sure your browser is accepting cookies.










Type the characters you see in this image:








Try different image











Continue shopping











Conditions of Use




Privacy Policy


          © 1996-2014, Amazon.com, Inc. or its affiliates
          


















Amazon.com: Amazon Music Unlimited








































Interesting Finds Updated Daily










Amazon




    Try Prime
  


















Digital Music



All Departments
Alexa Skills
Amazon Devices
Amazon Video
Amazon Warehouse Deals
Appliances
Apps & Games
Arts, Crafts & Sewing
Automotive Parts & Accessories
Baby
Beauty & Personal Care
Books
CDs & Vinyl
Cell Phones & Accessories
Clothing, Shoes & Jewelry
   Women
   Men
   Girls
   Boys
   Baby
Collectibles & Fine Art
Computers
Courses
Credit and Payment Cards
Digital Music
Electronics
Gift Cards
Grocery & Gourmet Food
Handmade
Health, Household & Baby Care
Home & Business Services
Home & Kitchen
Industrial & Scientific
Kindle Store
Luggage & Travel Gear
Luxury Beauty
Magazine Subscriptions
Movies & TV
Musical Instruments
Office Products
Patio, Lawn & Garden
Pet Supplies
Prime Exclusive
Prime Pantry
Software
Sports & Outdoors
Tools & Home Improvement
Toys & Games
Vehicles
Video Games
Wine





Go

















Departments









EN

 
      




Hello. Sign inAccount & ListsSign inAccount & ListsOrdersTry PrimeCart0






Your Amazon.comToday's DealsGift Cards & RegistrySellHelpDisability Customer Support 






 Amazon Music Unlimited Prime Music CDs & Vinyl Download Store         Open Web Player MP3 cart Settings













































































































$7.99/mo for Prime members




Non-Prime price: $9.99/month



Change or cancel anytime




            Start your 30-day free trial
          




$7.99/mo for Prime members




Non-Prime price: $9.99/month



Change or cancel anytime




            Start your 30-day free trial
          




$7.99/mo for Prime members




Non-Prime price: $9.99/month



Change or cancel anytime




            Start your 30-day free trial
          
















Any song, anywhere




Tens of millions of songs with new releases from today's most popular artists. Listen ad-free with unlimited skips. Download for offline listening.




Any song, anywhere




Tens of millions of songs with new releases from today's most popular artists. Listen ad-free with unlimited skips. Download for offline listening.




Any song, anywhere




Tens of millions of songs with new releases from today's most popular artists. Listen ad-free with unlimited skips. Download for offline listening.
















Already using Prime Music?




Upgrade to Amazon Music Unlimited now to unlock tens of millions of songs, including the hottest new releases. Only $7.99/month or $79/year (12 months for the price of 10).




Already using Prime Music?




Upgrade to Amazon Music Unlimited now to unlock tens of millions of songs, including the hottest new releases. Only $7.99/month or $79/year (12 months for the price of 10).




Already using Prime Music?




Upgrade to Amazon Music Unlimited now to unlock tens of millions of songs, including the hottest new releases. Only $7.99/month or $79/year (12 months for the price of 10).
















Better with Echo - Just ask




Play your favorite music with innovative Alexa voice controls, exclusive to Amazon Music.




Want Amazon Music Unlimited just on your Echo? Learn More




Better with Echo - Just ask




Play your favorite music with innovative Alexa voice controls, exclusive to Amazon Music.




Want Amazon Music Unlimited just on your Echo? Learn More




Better with Echo - Just ask




Play your favorite music with innovative Alexa voice controls, exclusive to Amazon Music.




Want Amazon Music Unlimited just on your Echo? Learn More


























Choose the right Amazon Music plan for you




Learn More




Learn More




Learn More




Questions? See our FAQ.





            Start free trial
          




Choose the right Amazon Music plan for you




Learn More




Learn More




Learn More




Questions? See our FAQ.





            Start free trial
          




Choose the right Amazon Music plan for you




Learn More




Learn More




Learn More




Questions? See our FAQ.





            Start free trial
          

















There's a problem loading this menu right now.
Learn more about Amazon Prime.






 Get fast, free shipping with Amazon Prime 
 Prime members enjoy FREE Two-Day Shipping and exclusive access to music, movies, TV shows, original audio series, and Kindle books. 

      >
      Get started

















v























